Form 8-K - Current report:
SEC Accession No. 0001213900-20-042028
Filing Date
2020-12-10
Accepted
2020-12-10 16:33:09
Documents
9
Period of Report
2020-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131376-8k_aytubioscience.htm 8-K 66533
2 AGREEMENT AND PLAN OF MERGER, DATED AS OF DECEMBER 10, 2020, BY AND AMONG AYTU B ea131376ex2-1_aytubio.htm EX-2.1 871084
3 COMMITMENT LETTER, DATED AS OF DECEMBER 10, 2020, BY AND BETWEEN AYTU BIOSCIENCE ea131376ex10-1_aytubio.htm EX-10.1 116062
4 DEERFIELD LOAN FACILITY AGREEMENT, DATED AS OF MAY 11, 2016, BY AND AMONG NEOS A ea131376ex10-2_aytubio.htm EX-10.2 210551
5 LOAN AND SECURITY AGREEMENT, DATED AS OF OCTOBER 2, 2019 ea131376ex10-3_aytubio.htm EX-10.3 46648
6 VOTING AND SUPPORT AGREEMENT ea131376ex10-4_aytubio.htm EX-10.4 43651
7 VOTING AND SUPPORT AGREEMENT ea131376ex10-5_aytubio.htm EX-10.5 43257
8 GRAPHIC ex10-2_001.jpg GRAPHIC 7504
9 GRAPHIC ex10-3_001.jpg GRAPHIC 6617
  Complete submission text file 0001213900-20-042028.txt   1418837
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201380988
SIC: 2834 Pharmaceutical Preparations